APA (7th ed.) Citation

S, Y., Y, X., M, J., C, L., Y, Z., C, G., . . . B, W. (2023). ER status conversion and subsequent treatment: An assessment of negative ER expression detected by 18F-FES PET in metastatic breast cancer patients with ER-positive primary tumors. Therapeutic advances in medical oncology, 15, 17588359231216093. https://doi.org/10.1177/17588359231216093

Chicago Style (17th ed.) Citation

S, You, et al. "ER Status Conversion and Subsequent Treatment: An Assessment of Negative ER Expression Detected by 18F-FES PET in Metastatic Breast Cancer Patients with ER-positive Primary Tumors." Therapeutic Advances in Medical Oncology 15 (2023): 17588359231216093. https://doi.org/10.1177/17588359231216093.

MLA (9th ed.) Citation

S, You, et al. "ER Status Conversion and Subsequent Treatment: An Assessment of Negative ER Expression Detected by 18F-FES PET in Metastatic Breast Cancer Patients with ER-positive Primary Tumors." Therapeutic Advances in Medical Oncology, vol. 15, 2023, p. 17588359231216093, https://doi.org/10.1177/17588359231216093.